Virtify Launches Clinical Trials Registry-India (CTR-I) Module

CAMBRIDGE, Mass., Sept. 14, 2011 /PRNewswire/ -- Virtify, Inc., the market leader in Structured Content Management solutions for life sciences, today announced the launch of the Clinical Trials Registry-India (CTR-I) module of its clinical trials registration and results management product, Virtify CTRR, making it the first disclosure solution in the market to support multiple registries. The CTR-I module is designed to help life science companies running clinical trials in India  do registration and results posting using an off-the-shelf, web-based product in a collaborative, structured content environment.

(Logo:  http://photos.prnewswire.com/prnh/20110131/NE38689LOGO )

As many of the world's leading life sciences companies try to support the ongoing regulatory requirement of achieving greater public advocacy and disclosure, Virtify CTRR enables companies to deploy a future-proof investment that solves today's challenges, with the flexibility to maintain compliance as global requirements evolve. Key features of Virtify CTRR include:

• A unified, state-of-the-art, web platform that is architected to meet the growing list of requirements around emerging global disclosure
• XML Rules Injection for seamless, rapid alignment with the different business rules from the emerging international registries in addition to the ongoing  changes to the PRS system
• Parallel Review and Approval for real-time collaboration between multiple authors and reviewers
• Open API's (Application Programming Interfaces) enabling integration with existing SAS or CTMS systems, or customer facing clinical trial sites
• Comprehensive professional services including software implementation, legacy data migration, regulatory & registry tracking, training and customer support
• Standard and custom reporting including audit trails
• Rapid implementation
• Flexible delivery via subscription or perpetual licenses, in-house or using hosted systems.

"We are really excited about the release of the CTR-I module. This is an important step in Virtify's global disclosure product initiative.  The CTR-I module will enable disclosure processes of organizations registering their trials in India using a single, unified platform," said Satish Tadikonda, president and CEO of Virtify. "Life sciences organizations with a global exposure are finding it difficult to keep pace with the continually changing regulatory climate. Virtify CTRR is the answer to many of the disclosure complexities that make it a daily struggle to comply with multiple registry requirements in a timely, efficient and profitable manner."

Virtify will be exhibiting at DIA's conference "The Evolving Clinical Trial Disclosure Landscape" at Arlington, VA on September 13-14.

About Virtify

Virtify is the market leader in Structured Content Management software solutions for life sciences. Organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's easy-to-use software suite is the industry's only solution to provide a secure, collaborative, web-based environment for managing regulated content throughout the entire continuum – from pre-clinical through product registration to commercialization.  www.virtify.com

SOURCE Virtify, Inc.